30 Sep 2021 Biotalys strengthens executive team with the appointment of Patrick McDonnell as Chief Business Officer Member news
30 Sep 2021 OXURION announces positive results from Part A of Phase 2 Study evaluating THR-149 for treatment of Diabetic Macular Edema (DME) Member news
29 Sep 2021 Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC) Member news
23 Sep 2021 Biocartis announces restart of its high-throughput cartridge manufacturing line Member news
22 Sep 2021 Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer Member news
22 Sep 2021 Donesta® Phase III: recruitment completion of American study and additional recruitment in the European study Member news
17 Sep 2021 Galapagos announces positive CHMP opinion for Jyseleca® (filgotinib) for the treatment of adults with moderately to severely active ulcerative colitis Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
